IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment by Gilbert Aaron Lee, Justin Bo-Kai Hsu, Yu-Wei Chang, Li-Chun Hsieh, Yi-Tien Li, Ying Chieh Wu, Cheng-Ying Chu, Yung-Hsiao Chiang, Wan-Yuo Guo, Chih-Chun Wu, Liang-Wei Chen, Hung-Wen Kao, Wan-Li Lin, Li‑Wen Tseng, Ting-Wei Weng, Duen-Pang Kuo, Sho-Jen Cheng, Yung-Chieh Chen, Shiu-Wen Huang, Hsing-Jien Kung, Cheng-Yu Chen

Subjects: Get full text

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors by Supriya Mallick, Ajeet Kumar Gandhi, Nikhil P Joshi, Anupam Kumar, Tarun Puri, Daya Nand Sharma, Kunhi Parambath Haresh, Subhash Gupta, Pramod Kumar Julka, Goura Kisor Rath, Chitra Sarkar

Subjects: Get full text

Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy by Gu W, Tang J, Liu P, Gan J, Lai J, Xu J, Deng J, Liu C, Wang Y, Zhang G, Yu F, Shi C, Fang K, Qiu F

Subjects: Get full text

Delta-radiomics Entropy Based on Tumor Heterogeneity Concept – Response Predictor to Irradiation for Unresectable/recurrent Glioblastoma by Camil Ciprian MIRESTEAN, Roxana Irina IANCU, Dragos Teodor IANCU

Subjects: Get full text

Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights by Hengzeng Li, Yahui Wu, Yue Chen, Jinquan Lv, Chengkang Qu, Tingjie Mei, Yunfan Zheng, Cheng Ye, Feifei Li, Shuo Ge, Anhui Yao, Liyun Jia

Subjects: “…Temozolomide…”
Get full text

99mTc-Tetrofosmin uptake correlates with the sensitivity of glioblastoma cell lines to temozolomide by George Alexiou, Xanthi Xourgia, Paraskevi Gerogianni, Evrysthenis Vartholomatos, John Kalef-Ezra, Andreas Fotopoulos, Athanasios Kyritsis

Subjects: Get full text

Efficacy of D,L-methadone in the treatment of glioblastoma in vitro by Konstantin Brawanski, Gero Brockhoff, Peter Hau, Arabel Vollmann-Zwerenz, Christian Freyschlag, Annette Lohmeier, Markus J Riemenschneider, Claudius Thomé, Alexander Brawanski, Martin A Proescholdt

Subjects: Get full text

Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction by Supriya Mallick, Ajeet Kumar Gandhi, Goura Kishor Rath

Subjects: Get full text

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma by Justyna Magdalena Przystal, Sajee Waramit, Md Zahidul Islam Pranjol, Wenqing Yan, Grace Chu, Aitthiphon Chongchai, Gargi Samarth, Nagore Gene Olaciregui, Ghazaleh Tabatabai, Angel Montero Carcaboso, Eric Ofori Aboagye, Keittisak Suwan, Amin Hajitou

Subjects: Get full text

Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway by Görkem Tutal Gürsoy, Mehmet Cudi Tuncer, İlhan Özdemir

Subjects: Get full text

Nephrogenic diabetes insipidus associated with temozolomide therapy in a patient with grade IV astrocytoma by Zayd Fargouche, Martin Manderlier, Anne-Pascale Meert, Louis Wolff, Maxime Ilzkovitz

Subjects: Get full text

Efficacy and Safety of Prolonged Adjuvant Temozolomide Treatment in Glioblastoma: Prospective Study of 81 Patients Undergoing up to 101 Cycles of Treatment by Giulio Bonomo, Francesco Certo, Erica Grasso, Giuseppa Fiumanò, Davide Barbagallo, Rosario Caltabiano, Giuseppe Broggi, Gaetano Magro, Andrea Maugeri, Antonella Agodi, Fiorenza Latteri, Hector Sotoparra, Giovanni Buscema, Corrado Spatola, Alessandro Pluchino, Giuseppe M. V. Barbagallo

Subjects: Get full text

Synergistic effect of perampanel with temozolomide on glioblastoma cells in vivo by Takuma Nishide, Shun Yamamuro, Emiko Sano, Yumi Aida, Kaoru Nara, Genki Yazawa, Yoshinari Ozawa, Atsuo Yoshino

Subjects: Get full text

A quantitative characterization of the heterogeneous response of glioblastoma U-87 MG cell line to temozolomide by Pragyesh Dixit, Ilyas Djafer-Cherif, Saumil Shah, Karolina Drabik, Arne Traulsen, Bartlomiej Waclaw

Subjects: Get full text

Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma by Caineng Cao, Le Wang, Feng Jiang, Qifeng Jin, Ting Jin, Shuang Huang, Qiaoying Hu, Yuanyuan Chen, Yongfeng Piao, Yonghong Hua, Xinglai Feng, Yi Zhou, Xiaozhong Chen

Subjects: Get full text

Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance by Laura Zarzuela, Raúl V. Durán, Mercedes Tomé

Subjects: Get full text

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma by Emil Lou, Katherine B. Peters, Ashley L. Sumrall, Annick Desjardins, David A. Reardon, Eric S. Lipp, James E. Herndon II, April Coan, Leighann Bailey, Scott Turner, Henry S. Friedman, James J. Vredenburgh

Subjects: Get full text

The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis. by Made Agus Mahendra Inggas, Utsav Patel, Jeremiah Hilkiah Wijaya, Nina Otinashvili, Vyshnav Rajagopal Menon, Abhay Krishnan Iyer, Tawfiq Turjman, Surbhi Dadwal, Mari Gadaevi, Azada Ismayilova, Shiva Jashwanth Gaddam, Prakriti Arya, Nihar Upadhyay, Saurabh Kataria

Subjects: Get full text

COX-2 Inhibition in Glioblastoma Cells Counteracts Resistance to Temozolomide by Inducing Oxidative Stress by Francesca Rosaria Augello, Francesca Lombardi, Valeria Ciummo, Alessia Ciafarone, Maria Grazia Cifone, Benedetta Cinque, Paola Palumbo

Subjects: Get full text

Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells by Samantha L. Gerlach, James S. Metcalf, Rachael A. Dunlop, Sandra Anne Banack, Cheenou Her, Viswanathan V. Krishnan, Ulf Göransson, Sunithi Gunasekera, Blazej Slazak, Paul Alan Cox

Subjects: Get full text